Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Mancin, A
Gray M, Zillioux J, Khourdaji I, Smith RP
The educational offering comes as Morgan Stanley Research projects that more than 24 million Americans will use weight loss medications by 2035 and consumer spending on GLP-1s has skyrocketed in the United States
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Blood pressure support and overall energy and detox support are witnessing moderate growth, driven by the rising prevalence of lifestyle-related disorders
Additional Information Topic: Healthcare Utilization / Cost Transparency Source Link: Cost Transparency Healthcare Payments Database Citation: HCAI Healthcare Payments Database GLP-1 Prescriptions for Weight Loss Over Time, April 2026 Temporal Coverage: 2018-2023 Spatial/Geographic Coverage: Statewide, County Frequency: Annually Looking for related content
Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, and TransCon are trademarks owned by the Ascendis Pharma group
US$ 20.38
US$ 23.87
US$ 26.27
US$ 28.38
US$ 23.79
US$ 26.03
US$ 27.03
US$ 27.51
US$ 21.43
US$ 22.09
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
